The bigger problem is that these companies charge far less for their products in wealthy countries that are perfectly capable of paying the same price as U.S. consumers but refuse to do so because they have government-run health care systems that control everything from top to bottom.
I thought a primary concern of FReepers was their stock portfolio.
I think you might want to dump any pharma based on Schiff’s comments. He’s not often wrong about economics anyway...